Prot# CC-5013-MM-009: A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Study of CC-5013 Plus Dexamethasone versus Dexamthasone Alone in Previously Treated Subjects with Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date4/23/03 → 6/30/11

Funding

  • Celgene Corporation (CC-5013-MM-009)